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Abstract 13 
Inflammatory Bowel Disease (IBD) is commonly associated with poor global sleep 14 
quality, and has been posited as a modifiable determinant of IBD related outcomes, with 15 
recent calls to screen for, and subsequently treat problems sleeping as part of routine IBD 16 
care. However, there is little evidence on the specific types of problems sleeping (e.g., sleep 17 
apnea, insomnia etc.) that might characterize the poor sleep quality experienced by those with 18 
IBD. The present research aimed to investigate the severity of seven specific types of 19 
problems sleeping in those with IBD vs. a healthy control group. This cross-sectional 20 
comparison study recruited N = 409 with IBD, and N = 377 healthy controls (total sample N 21 
= 786). The Sleep-50 questionnaire was used to assess the presence of seven types of 22 
problems sleeping. Multivariate Analysis of Covariance (MANCOVA) was used to compare 23 
the severity of sleep disturbances between the IBD and control groups. Those in the IBD 24 
group reported significantly more severe experiences of five of the seven domains of the 25 
Sleep-50, including increased; sleep apnea, insomnia, narcolepsy, restless legs, and 26 
nightmares. In conclusion, those with a diagnosis of IBD reported significantly more severe 27 
symptoms across a range of specific problems sleeping when compared to controls. More 28 
research is needed to; i) improve the identification and treatment of problems sleeping in 29 
routine care; ii) understand the mechanism(s) of action that links problems sleeping to IBD 30 
related outcomes; and iii) develop adapted interventions to improve sleep in those with IBD.  31 
Word count: 246 32 
Keywords:  Sleep; Inflammatory Bowel Disease; IBD; Crohn’s Disease; Ulcerative 33 
Colitis. 34 
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A Comparative Study of the Nature and Magnitude of Problems Sleeping in 36 
Inflammatory Bowel Disease (IBD) Compared to Healthy Controls  37 
In recent years, there has been a proliferation of research aiming to better understand 38 
the role of sleep in a range of physical (Gallicchio & Kalesan, 2009; O'brien et al., 2010; 39 
Pavlova, Ference, Hancock, & Noel, 2017; Wong et al., 2013), and mental health difficulties 40 
(Baglioni et al., 2011; Scott, Rowse, & Webb, 2017; Taylor, Lichstein, Durrence, Reidel, & 41 
Bush, 2005). The association between problems sleeping and health is particularly apparent 42 
in those with Inflammatory Bowel Disease (IBD) - a chronic and incurable disease involving 43 
inflammation of the gastrointestinal tract – where poor sleep quality is commonly reported 44 
(Kinnucan, Rubin, & Ali, 2013; Swanson, Burgess, & Keshavarzian, 2011; Wilson et al., 45 
2015). Indeed, problems sleeping in those with IBD have been posited as a modifiable risk 46 
factor for a number of IBD related outcomes including diagnosis incidence (Ananthakrishnan 47 
et al., 2014), disease symptom flares (Ananthakrishnan, Long, Martin, Sandler, & 48 
Kappelman, 2013; Uemura et al., 2016), poorer health related quality of life (Keefer, 49 
Stepanski, Ranjbaran, Benson, & Keshavarzian, 2006; Ranjbaran, Keefer, Stepanski, Farhadi, 50 
& Keshavarzian, 2007; Uemura et al., 2016), and fatigue (Graff et al., 2013). However, 51 
despite a growing body of literature further elucidating our understanding of the experience 52 
of sleep in those with IBD, there remains a number of opportunities that would facilitate calls 53 
to screen for, and subsequently treat problems sleeping in those with IBD (Almedimigh et al., 54 
2018; Kinnucan et al., 2013). 55 
Opportunities for Advancement 56 
To date, the majority of research into the role of sleep disturbances in those with IBD 57 
has tended to rely on more global measures of sleep quality (e.g., the Pittsburgh Sleep Quality 58 
Index (PSQI); Buysse, Reynolds, Monk, Berman, & Kupfer, 1989), rather than measures able 59 
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has poor, or good self-reported sleep quality; however, it cannot tell us this is due to the 61 
experience of specific types of problems sleeping (e.g., due to insomnia, sleep apneoa, 62 
nightmares etc.). Although there is evidence suggesting that those with IBD may experience 63 
specific types of problems sleeping more commonly, including symptoms of sleep apnea 64 
(Keefer et al., 2006), restless legs (Becker et al., 2018; Keefer et al., 2006), and nightmares 65 
(Ranjbaran et al., 2007); the conclusions that can be drawn are limited - in that findings are 66 
often reliant on single-item measures of specific problems sleeping, and/or small sample sizes 67 
leading to underpowered studies. Consequently, is important that research also uses multi-68 
item measures of specific sleep disturbances along with larger samples to drawn more robust 69 
conclusions. Secondly, few studies have compared the problems sleeping seen in IBD to 70 
healthy controls (i.e., those without gastrointestinal diagnoses). Consequently, it is unclear 71 
whether both the type and magnitude of problems sleeping differ between those with, and 72 
without a diagnosis of IBD. 73 
The present research 74 
The lack of research investigating specific types of sleep disturbance in IBD relative 75 
to healthy controls serves to inhibit two important avenues; i) the development and adaption 76 
of interventions to target specific sleep disturbances experienced by those with IBD as a route 77 
to improving IBD related outcomes; and ii) as has been recently suggested, the incorporation 78 
of sleep disturbance screening into the routine clinical management of IBD (Almedimigh et 79 
al., 2018; Kinnucan et al., 2013). The present research aims to address this by measuring the 80 
severity of multiple types of specific problems sleeping in those with diagnosis of IBD 81 
relative to healthy controls. We hope that doing so will provide a more comprehensive profile 82 
of the types of problems sleeping that are experienced by people with IBD, with each type 83 
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Materials and Methods 85 
Participants 86 
The IBD group were recruited from three sources; (i) through an advertisement placed 87 
on a national IBD charity website in the UK (Crohn’s & Colitis UK); (ii) from IBD specific 88 
online support groups; and (iii) from volunteer lists maintained by the research team. The 89 
healthy control group was recruited from two sources; (i) from volunteer lists maintained by 90 
the research team; and (ii) via a social media advertising campaign. Enrolment to the study 91 
began in May 2017, and concluded in November 2017. Prior to taking part in the present 92 
research, all participants were asked a number of screening and eligibility questions. To be 93 
eligible for the IBD group, participants were required to; (i) have a diagnosis of IBD; and (ii) 94 
be at least 16 years of age or older. To be eligible for inclusion in the control group, 95 
participants were required to; (i) have no diagnosis of any gastrointestinal disorder (e.g., IBD, 96 
Irritable Bowel Syndrome, coeliac disease etc.); and (ii) be at least 16 years of age or older. 97 
Participants not meeting these criteria, those who did not provide full informed consent, and 98 
those who did not start the online survey were excluded. 99 
Procedure 100 
Participants were invited to take part in an online study aiming to investigate the 101 
severity of problems sleeping in those with, and without, a diagnosis of IBD. All outcome 102 
measures were delivered anonymously online using Qualtrics, a web based survey hosting 103 
platform (Qualtrics, 2018). Participants first read an information sheet detailing aspects of the 104 
research before confirming eligibility via a series of screening items in line with the studies 105 
inclusion and exclusion criteria. If eligible, participants provided electronic consent to 106 
participate. The Research Ethics Committee based in the School of Health and Related 107 
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Outcome Measures 109 
Demographics 110 
All participants were asked to provide information relating to their age, gender, and 111 
whether they were currently receiving psychological therapy and/or medication for a mental 112 
health or sleep related problem. Participants in the IBD group were asked a number of items 113 
relating to their IBD, including their IBD diagnosis type (Ulcerative Colitis or Crohn’s 114 
Disease), number of years living with an IBD diagnosis, whether they had ever undergone 115 
IBD related surgery, current and/or previous use of a stoma, and whether they were currently 116 
taking medication for their IBD.   117 
The Sleep-50 Questionnaire  118 
The Sleep-50 is a 50 item self-report instrument designed to measure symptoms of 119 
seven specific types of sleep disturbances (sleep apnea, insomnia, narcolepsy, restless legs, 120 
circadian rhythm disruption, sleepwalking, & nightmares), as well as factors influencing 121 
sleep (e.g., low mood, sleep environment not optimal, medication use), and the impact of 122 
sleep complaints of daily functioning (e.g., feeling tired on awakening, difficulty 123 
concentrating, worrying about sleep). Using a 4-point scale, participants are asked to rate the 124 
extent to which they endorse each item over the last 4-weeks, ranging from ‘not at all’ 125 
through to ‘very much’. The Sleep-50 has been validated for use in both general population 126 
samples, and those with clinically defined sleep disorders, demonstrating a clear factor 127 
structure, high internal consistency, and good test-retest reliability (Spoormaker, Verbeek, van 128 
den Bout, & Klip, 2005). 129 
The Short Inflammatory Bowel Disease Questionnaire (SIBDQ) 130 
The bowel symptoms subscale of the SIBDQ (Jowett, Seal, Barton, & Welfare, 2001) 131 
was used as a proxy measure of disease symptom activity in the IBD group. The bowel 132 
















Problems Sleeping in Inflammatory Bowel Disease 7 
three items pertaining to the frequency of IBD symptoms on a 5-point scale, with lower 134 
scores indicating more frequent symptom activity. For example, participants are asked, “How 135 
often in the last two weeks have you been troubled by pain in the abdomen?”. The bowel 136 
symptoms subscale correlates strongly with several validated measures of disease activity 137 
(Jowett et al., 2001), including the Simple Clinical Colitis Activity Index (SCCAI; Walmsley, 138 
Ayres, Pounder, & Allan, 1998), and the Seo index (Seo et al., 1992), suggesting its valid use 139 
as a proxy measure of disease activity. 140 
Approach to Analysis 141 
A one-way multivariate analysis of covariance (MANCOVA) was conducted to 142 
investigate the severity of seven specific types of sleep disturbances measured by the Sleep-143 
50, as well as factors influencing sleep, and the impact of sleep complaints on daily 144 
functioning in the IBD group relative to controls. Where the MANCOVA demonstrated 145 
significant differences between the IBD and control groups in terms of the type of problem 146 
sleeping, a sensitivity analysis in the form of hierarchical linear regression (including only the 147 
IBD group) was conducted to investigate whether any IBD related characteristics were 148 
significantly associated with the sleep disturbance. G-Power 3.1 (Faul, Erdfelder, Lang, & 149 
Buchner, 2007) was used to determine the sample size. For the MANCOVA, based on a 150 
small-to-medium sized effect at 90% power, and a strict significance threshold of p < .001, 151 
the desired total sample size is N = 560. Given that the heirarchical linear regression includes 152 
only the IBD group, a less conservative alpha level was set; based on a small-to-medium 153 
sized effect at 90% power, and a significance threshold of p < .05, the desired total sample 154 
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Results 156 
Participants 157 
Of the N = 498 participants in the IBD group who started the study procedures, N = 158 
409 (82%) were included in the study, with N = 89 (18%) excluded. Of those excluded in the 159 
IBD group, N = 9 (10%) were under the age of 16, N = 7 (8%) had no diagnosis of IBD, N = 160 
22 (25%) did not provide consent to take part, and N = 51 (57%) did not start the online 161 
surveys. With regards to the control group, N = 472 began the study procedures with N = 377 162 
(88%) included in the study. Of the N = 50 (12%) who were excluded, N = 3 (6%) were under 163 
the age of 16, N = 4 (8%) had a diagnosis of IBD, N = 20 (40%) had diagnosis of Irritable 164 
Bowel Syndrome (IBS), N = 10 (20%) did not provide consent to take part, and N = 13 (26%) 165 
did not start the online surveys. Figure 1 describes of the flow of participants through the 166 
study, while Table 1 presents the demographic and clinical characteristics of both groups.  167 
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Figure 1 169 
 170 
A CONSORT Flow Diagram Showing the Flow of Participants Through the Study 171 
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Table 1 173 
Baseline Sample Characteristics of the IBD and Control Group 174 
Variable IBD group (N = 409) Control group (N = 377) 
Age, M (SD) 33.86 (11.57) 39.60 (14.51) 
Gender, N (%)   
Male 74 (18%) 100 (27%) 
Female 335 (82%) 277 (73%) 
Sleep medication use, N (%)   
Yes 96 (23%) 17 (5%) 
No 313 (77%) 360 (95%) 
Sleep therapy, N (%)   
Yes 21 (5%) 3 (1%) 
No 388 (95%) 374 (99%) 
IBD type, N (%)   
Ulcerative Colitis (UC) 155 (38%) - 
Crohn's Diseases (CD) 254 (62%) - 
Years with IBD diagnosis, M 
(SD) 
9.12 (8.52) - 
Surgery for IBD, N (%)   
Yes 172 (42%) - 
No 237 (58%) - 
Current stoma, N (%)   
Yes 58 (14%) - 
No 351 (86%) - 
Previous stoma, N (%)   
Yes 64 (16%) - 
No 345 (84%) - 
Immunosuppressant use, N (%)   
Yes 259 (63%) - 
No 150 (37%) - 
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Does specific sleep disturbance severity differ between groups? 176 
MANCOVA (controlling for age and gender) was used to examine whether the 177 
severity of specific sleep disturbances differed between those in the IBD group vs. the control 178 
group (see Table 2 for an overview of these analyses). There was a statistically significant 179 
multivariate difference between groups (F(9, 774) = 50.44, p < 0.001, Eta2 = 0.08), in that 180 
participants in the IBD group reported significantly more profound sleep disturbance than the 181 
control group. This effect was reflected in significantly more severe sleep disturbance across 182 
seven of the eight subscales measured by the Sleep-50, including symptom severity of; sleep 183 
apnea (F(1, 782) = 12.94, p < 0.001, Eta2 = 0.02), insomnia (F(1, 782) = 31.89, p < 0.001, 184 
Eta2 = 0.04), narcolepsy (F(1, 782) = 16.01, p < 0.001, Eta2 = 0.02), restless legs (F(1, 782) 185 
= 17.98, p < 0.001, Eta2 = 0.02), nightmares (F(1, 782) = 13.87, p < 0.001, Eta2 = 0.02), 186 
factors influencing sleep (F(1, 782) = 35.81, p < 0.001, Eta2 = 0.04), and the impact of 187 
sleep disturbance on daily life (F(1, 782) = 63.69, p < 0.001, Eta2 = 0.08). There were no 188 
significance differences between groups on the severity of circadian rhythm disruptions 189 
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Table 2 192 
Descriptive Statistics and Between Group Comparisons of Sleep Disorder(s) in the IBD group vs. Controls 193 
 IBD group (N = 409) Control group (N = 377)    
Sleep outcome M SD M SD F p Eta2 
Sleep-50 total 95.47 20.48 84.88 21.38 50.44 < 0.001 0.08 
Sleep apnoea 14.03 3.49 13.19 3.99 12.94 < 0.001 0.02 
Insomnia 20.33 3.49 17.99 5.57 31.89 < 0.001 0.04 
Narcolepsy 7.74 2.34 7.06 2.29 16.01 < 0.001 0.02 
Restless legs 6.59 2.47 5.87 2.41 17.98 < 0.001 0.02 
Circadian rhythm disruption 5.23 2.01 4.79 1.80 7.34 0.01 0.01 
Sleepwalking 3.36 0.99 3.23 0.78 4.48 0.04 0.01 
Nightmares 8.29 5.51 6.73 5.65 13.87 < 0.001 0.02 
Factors influencing sleep 11.09 2.71 9.94 2.50 35.81 < 0.001 0.04 
Impact on daily function 18.89 4.87 16.08 5.18 63.69 < 0.001 0.08 
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Clinical correlates of sleep disturbance in the IBD group 195 
Where there was a significant difference between the IBD and control group in the 196 
preceding analysis, a sensitivity analysis was conducted using only the IBD group to investigate 197 
potential clinical correlates of sleep disturbances. Table 3 presents the detailed results of this 198 
analysis; however, in short, none of the characteristics of the IBD group were associated with the 199 
experience of sleep apnoea (F(8, 375) = 0.61, p = 0.77), narcolepsy (F(8, 375) = 0.46, p = 0.88), 200 
or nightmares (F(8, 375) = 0.71, p = 0.68). However, a higher IBD symptom activity as 201 
measured by the bowel symptom subscale of the SIBDQ was negatively associated with 202 
increased insomnia severity (β = -0.14, p = 0.01), restless legs symptom severity (β = -0.14, p = 203 
0.03), increased factors influencing sleep, (β = -0.15, p = 0.01), and increased impact of sleep 204 
disturbances on daily function (β = -0.13, p = 0.01). Furthermore, IBD diagnosis type was 205 
associated with the impact of sleep complaints on daily function (β = 0.14, p = 0.01), with those 206 
diagnosed with Ulcerative Colitis reporting more daily impact. 207 
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Table 3 209 
Clinical Correlates of Specific Sleep Disturbances in the Inflammatory Bowel Disease (IBD) 210 
Group 211 
Sleep problem β t p 
Sleep apnea    
Age -0.02 -0.31 0.75 
Gender -0.02 -0.40 0.69 
IBD type 0.02 0.30 0.76 
Years with IBD -0.01 -0.09 0.93 
IBD surgery 0.06 0.91 0.36 
Current stoma 0.04 0.74 0.46 
IBD medication 0.01 0.27 0.79 
IBD symptom activity -0.02 -0.44 0.66 
Insomnia    
Age -0.10 -1.62 0.11 
Gender -0.05 -0.91 0.36 
IBD type 0.02 0.37 0.71 
Years with IBD 0.05 0.79 0.43 
IBD surgery -0.07 -1.02 0.31 
Current stoma 0.06 1.01 0.31 
IBD medication 0.04 0.78 0.44 
IBD symptom activity -0.12 -2.21 0.03 
Narcolepsy    
Age -0.03 -0.55 0.59 
Gender 0.02 0.43 0.66 
IBD type 0.06 0.98 0.33 
Years with IBD -0.04 -0.65 0.52 
IBD surgery -0.05 -0.81 0.42 
Current stoma -0.03 -0.46 0.65 
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IBD symptom activity -0.04 -0.65 0.51 
Restless legs    
Age 0.04 0.75 0.45 
Gender 0.02 0.31 0.75 
IBD type -0.01 -0.19 0.85 
Years with IBD -0.02 -0.24 0.81 
IBD surgery -0.01 -0.20 0.84 
Current stoma 0.07 1.13 0.26 
IBD medication 0.01 0.10 0.92 
IBD symptom activity -0.12 -2.22 0.03 
Nightmares    
Age 0.01 0.19 0.85 
Gender 0.04 0.76 0.45 
IBD type 0.01 0.12 0.91 
Years with IBD -0.10 -1.53 0.13 
IBD surgery -0.11 -1.76 0.08 
Current stoma 0.10 1.67 0.10 
IBD medication -0.02 -0.32 0.75 
IBD symptom activity 0.06 1.16 0.25 
Factors influencing sleep    
Age -0.05 -0.81 0.42 
Gender -0.04 -0.80 0.42 
IBD type 0.07 1.22 0.22 
Years with IBD 0.07 1.11 0.27 
IBD surgery -0.06 -0.92 0.36 
Current stoma 0.04 0.71 0.48 
IBD medication 0.06 1.13 0.26 
IBD symptom activity -0.15 -2.70 0.01 
Impact on daily function    
Age 0.02 0.35 0.73 
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IBD type 0.14 2.56 0.01 
Years with IBD 0.01 0.17 0.86 
IBD surgery -0.06 -0.99 0.32 
Current stoma -0.07 -1.13 0.26 
IBD medication 0.01 0.26 0.79 
IBD symptom activity -0.13 -2.48 0.01 
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Discussion 213 
The present research aimed to investigate the nature and magnitude of specific types of 214 
problems sleeping in those with IBD relative to a healthy control group (i.e., no gastrointestinal 215 
diagnoses). Our findings suggest that relative to controls, those with IBD reported significantly 216 
more severe symptoms of five of the seven sleep disturbances measured by the Sleep-50, 217 
including; sleep apnea, insomnia, narcolepsy, restless legs, and nightmares. Furthermore, those 218 
with IBD reported experiencing significantly more factors that are known to influence sleep 219 
(e.g., low mood, sleep environment not optimal, medication use), and a greater impact of sleep 220 
disturbances on daily life (e.g., feeling tired on awakening, difficulty concentrating, worrying 221 
about sleep). Interestingly, only the experience of insomnia, and the impact of sleep disturbances 222 
on daily life was associated with some clinical features of IBD. Greater insomnia severity was 223 
associated with more frequent IBD symptoms, whereas a diagnosis of Ulcerative Colitis was 224 
significantly associated with a greater impact of sleep disturbances on daily life. 225 
The key finding reported in the present research is that those with IBD reported more 226 
severe experiences of a variety of specific problems sleeping, including; sleep apnea, insomnia, 227 
narcolepsy, restless legs, and nightmares, as well as more disruptions to factors known to 228 
influence sleep, and a greater impact of sleep disturbances on daily life. Although the majority of 229 
extant research reports the association between global sleep quality and IBD, the few studies that 230 
have examined specific types of problems sleeping are supported by the present research. For 231 
example, the findings reported here support previous research suggesting that those with IBD 232 
experience sleep disordered breathing (i.e., a core symptom of sleep apnoea, Keefer et al., 2006), 233 
restless legs (Becker et al., 2018; Keefer et al., 2006), and nightmares (Ranjbaran et al., 2007). 234 
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specific problems sleeping, the findings reported here also extend previous work by reporting an 236 
increased severity of insomnia, and narcolepsy symptoms in the IBD group relative to controls. 237 
Although more research is warranted, these findings suggest that the routine care of those with 238 
IBD might consider incorporating assessments to screen for the presence a variety of specific 239 
types of problems sleeping. 240 
Future directions 241 
It seems clear that problems sleeping are associated with IBD, and may even represent a 242 
core experience of IBD itself (Keefer et al., 2006). However, how problems sleeping are related 243 
to IBD, and the direction that best explains this association is currently unclear. Consequently, 244 
future research might seek to elucidate the mechanisms of action that can explain how problems 245 
sleeping can exert an effect on IBD related outcomes, using designs able to inform the direction 246 
of effect. Research that is well placed to disentangle the impact of mediators and the direction of 247 
association between sleep and IBD outcomes are those that employ longitudinal designs (i.e., 248 
designs that measure variables over time, so that the temporal relationship between variables can 249 
be investigated), research that is currently lacking (for notable exceptions, see Ananthakrishnan 250 
et al., 2014; Ananthakrishnan et al., 2013; Graff et al., 2013; Uemura et al., 2016). Problems 251 
sleeping have been posited as a possible modifiable environmental risk factor that can adversely 252 
affect IBD outcomes. However, despite recent calls to screen for, and subsequently treat 253 
problems sleeping in those with IBD (Almedimigh et al., 2018; Kinnucan et al., 2013), there are 254 
relatively few guidelines to facilitate clinical decision making in this area (National Institute for 255 
Health and Care Excellence, 2015; Kinnucan et al., 2013). Therefore, future research might 256 
profitably seek to understand the barriers and facilitators to effective sleep management in 257 
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developing effective guidelines to facilitate the detection and subsequent treatment of specific 259 
sleep disturbances in those with IBD.  260 
Limitations of the present research 261 
Firstly, the present study recruited participants based on a self-reported IBD diagnosis. 262 
Although recent research has demonstrated that self-reported diagnosis in online research has a 263 
high concordance rate with physician diagnoses (Kelstrup, Juillerat, & Korzenik, 2014; Randell 264 
et al., 2014), this should be taken into account when considering the present findings. Secondly, a 265 
large proportion of the participants from which the present findings are based are female. This is 266 
perhaps not surprising given that there is evidence to suggest that there is a greater prevalence of 267 
IBD in women when compared to men (Bernstein, Blanchard, Rawsthorne, & Wajda, 1999; 268 
Brant & Nguyen, 2008). Indeed, findings based on majority female participants are a common 269 
occurrence in the sleep-IBD literature (Ananthakrishnan et al., 2014; Ananthakrishnan et al., 270 
2013; Graff et al., 2013), and in epidemiological research more broadly (Dunn, Jordan, Lacey, 271 
Shapley, & Jinks, 2004; Galea & Tracy, 2007; Smith, 2008). The large sample size in the present 272 
research does mitigate some of the effects of sample representativeness, and the analyses 273 
controlled the effects of gender (gender was not associated with outcomes). That being said, the 274 
gender distributions in the present research need to be taken into account when interpreting the 275 
findings. 276 
Conclusions 277 
The present research found that, relative to controls, those with a diagnosis of IBD 278 
reported significantly more severe experiences of sleep apnea, insomnia, narcolepsy, restless 279 
legs, and nightmares, as well as more factors that influence sleep, and a greater impact of sleep 280 
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avenues; i) investigation of the barriers/facilitators to the effective management of problems 282 
sleeping in the routine care of those with IBD; ii) research aiming to elucidate the directional 283 
association between sleep and IBD related outcomes, as well as any mechanisms of action; and 284 
iii) the effectiveness and efficacy of interventions designed to improve sleep as a route to 285 
improving IBD related outcomes. We hope that the present research will highlight the nature and 286 
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